Research Articles
Feeder-Free Human ESC Culture: Protocols, Matrices & Media for Defined Conditions in 2024
This comprehensive guide explores feeder-free culture systems for human embryonic stem cells (hESCs), addressing key needs of researchers and drug developers.
The Ethical Frontier and Clinical Promise of Embryonic Stem Cell Research
This article provides a comprehensive, evidence-based analysis of the ethical debate surrounding embryonic stem cell research (ESCR), specifically tailored for research scientists, drug developers, and biomedical professionals.
Human Blastocyst Moral Status: The Ethical Core and Scientific Frontier of Stem Cell Research
This article examines the central ethical dilemma in stem cell research: the moral status of the human blastocyst.
Navigating the Evolving Landscape of Accelerated Approval Pathways for Rare Diseases
This article provides a comparative analysis of expedited regulatory pathways for rare disease therapies, focusing on recent innovations like the FDA's Plausible Mechanism Pathway and Rare Disease Evidence Principles.
Validating Biometric Monitoring Technologies: A 2025 Regulatory Framework for Clinical Research and Drug Development
This article provides researchers, scientists, and drug development professionals with a comprehensive guide to the evolving regulatory landscape for Biometric Monitoring Technologies (BioMeTs) in 2025.
Navigating Regulatory Pathways: A Strategic Guide to Biomarker Endpoint Validation in Drug Development
This article provides researchers, scientists, and drug development professionals with a comprehensive guide to the validation of biomarker endpoints across major regulatory frameworks.
The V3 Framework: A Comprehensive Guide to Verification and Validation for Digital Medicine Products
This article provides researchers, scientists, and drug development professionals with a detailed exploration of the Verification, Analytical Validation, and Clinical Validation (V3) framework for digital medicine products.
Bridging Oceans: A Comparative Analysis of Regulatory Support Mechanisms for Drug Development in the US and Japan
This article provides a comprehensive comparative analysis of the evolving regulatory support mechanisms in the United States and Japan, two of the world's largest pharmaceutical markets.
Analytical Method Validation Parameters: A Comprehensive Comparison of ICH, EMA, WHO, and ASEAN Guidelines
This article provides a detailed comparative analysis of analytical method validation (AMV) requirements across four major regulatory frameworks: the International Council for Harmonisation (ICH), European Medicines Agency (EMA), World Health...
Navigating Regulatory Pathways: A Comparative Analysis of Drug Approval Efficiency and Effectiveness
This article provides a comprehensive analysis of the comparative effectiveness of different regulatory approval pathways, tailored for researchers, scientists, and drug development professionals.